Cheng-Tao Jiang
Overview
Explore the profile of Cheng-Tao Jiang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
80
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tang C, Li X, Zhou T, Deng C, Jiang C, Zhang Y, et al.
Clin Epigenetics
. 2024 Jan;
16(1):11.
PMID: 38212818
Background: As an oncovirus, EBV is associated with multiple cancers, including solid tumors and hematological malignancies. EBV methylation plays an important role in regulating tumor occurrence. However, the EBV methylation...
2.
Deng C, Wang T, He Y, Zhang W, Xue W, Li D, et al.
J Med Virol
. 2023 Jun;
95(6):e28860.
PMID: 37310118
Human leukocyte antigen (HLA) molecules are essential for presenting Epstein-Barr virus (EBV) antigens and are closely related to nasopharyngeal carcinoma (NPC). This study aims to systematically investigate the association between...
3.
Zheng X, Deng C, Zhou T, Li X, Tang C, Jiang C, et al.
Int J Cancer
. 2023 May;
153(4):882-892.
PMID: 37170851
Saliva sampling is a non-invasive method, and could be performed by donors themselves. However, there are few studies reporting biomarkers in saliva in the diagnosis of NPC. A total of...
4.
Zheng X, Li X, Zhou T, Jiang C, Tang C, Deng C, et al.
Int J Cancer
. 2023 Mar;
152(12):2629-2638.
PMID: 36878711
Detecting EBV DNA load in nasopharyngeal (NP) brushing samples for the diagnosis of nasopharyngeal carcinoma (NPC) has attracted widespread attentions. Currently, NP brush sampling mostly relies on endoscopic guidance, and...
5.
Jiang C, Chen K, Liu A, Huang H, Fan Y, Zhao D, et al.
Nat Commun
. 2021 Mar;
12(1):1359.
PMID: 33649336
Modulating effector immune cells via monoclonal antibodies (mAbs) and facilitating the co-engagement of T cells and tumor cells via chimeric antigen receptor- T cells or bispecific T cell-engaging antibodies are...
6.
Huang H, Jiang C, Shen S, Liu A, Gan Y, Tong Q, et al.
Nano Lett
. 2019 Jul;
19(8):5356-5365.
PMID: 31286779
Certain chemotherapeutics (e.g., oxaliplatin, OXA) can evoke effective antitumor immunity responses by inducing immunogenic cell death (ICD). Unfortunately, tumors always develop multiple immunosuppressive mechanisms, such as the upregulation of immunosuppressive...